Insider Transactions in Q1 2022 at Ekso Bionics Holdings, Inc. (EKSO)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 24
2022
|
Steven Sherman Executive Chair |
SELL
Open market or private sale
|
Direct |
6,389
-1.02%
|
$12,778
$2.94 P/Share
|
|
Mar 22
2022
|
Jason C Jones Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,265
-3.85%
|
$6,530
$2.82 P/Share
|
|
Mar 22
2022
|
John Glenn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,462
-8.97%
|
$6,924
$2.82 P/Share
|
|
Mar 21
2022
|
Steven Sherman Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
15,599
+2.43%
|
-
|
|
Mar 15
2022
|
Steven Sherman Executive Chair |
SELL
Open market or private sale
|
Direct |
5,965
-0.97%
|
$11,930
$2.6 P/Share
|
|
Mar 08
2022
|
Steven Sherman Executive Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
15,599
+2.47%
|
-
|
|
Feb 17
2022
|
Jason C Jones Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
3,346
+42.69%
|
-
|
|
Feb 17
2022
|
John Glenn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,596
+27.44%
|
-
|
|
Feb 17
2022
|
Jason C Jones Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,760
+13.95%
|
-
|
|
Feb 17
2022
|
William R Shaw Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,943
+15.62%
|
-
|
|
Feb 17
2022
|
Scott G. Davis President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
41,158
+34.58%
|
-
|